TLRY
Tilray Brands, Inc.
Key Financials
Net Income
$-121397000
↑ 94.4%
Gross Profit
$260.4M
↑ 8.3%
Operating Income
$-63027000
↑ 97.2%
EPS (Diluted)
$-1.09
↑ 55.7%
Revenue
$915.5M
↑ 11.5%
Total Assets
$2.3B
↑ 12.2%
Shareholders' Equity
$1.6B
↑ 6.8%
Total Liabilities
$733.1M
↑ 25.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| ARS | 9/28/2026 | View on SEC |
| DEFA14A | 9/28/2026 | View on SEC |
| DEF 14A | 9/28/2026 | View on SEC |
| PRE 14A | 9/18/2026 | View on SEC |
| 8-K | 9/14/2026 | View on SEC |
| 4 | 8/27/2026 | View on SEC |
| 4 | 8/27/2026 | View on SEC |
| 4 | 8/27/2026 | View on SEC |
| 4 | 8/27/2026 | View on SEC |
| 8-K | 8/10/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | TLRY |
| Company Name | Tilray Brands, Inc. |
| CIK | 1731348 |
| Sector | Medicinal Chemicals & Botanical Products |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2833 |
| SIC Description | Medicinal Chemicals & Botanical Products |
| Entity Type | operating |
| Fiscal Year End | 0531 |
| Phone | 519.322.8800 |